XI’AN, China, April 08, 2025 — Bon Natural Life Limited (Nasdaq: BON) (“BON” or “the Company”), a prominent provider of bio-ingredient solutions for the natural, health, and personal care sectors, has announced a biotech innovation. This innovation addresses critical nutritional challenges using a patent-pending Glucoraphanin-Myrosinase co-delivery system, which significantly boosts the bioactivity of glucoraphanin, a key bioactive compound found in broccoli.
Broccoli is a nutrient-dense superfood containing glucoraphanin, its primary bioactive compound, which can be metabolically converted into sulforaphane within the body. Sulforaphane is linked to various bioactive properties, including anti-cancer, sleep improvement, neuroprotection, digestive system enhancement, anti-inflammatory, antioxidant, and anti-aging effects. However, the precursor molecule requires enzymatic conversion to sulforaphane, the active form responsible for these effects. This biological conversion process is often challenging and inefficient, posing a major hurdle for effective nutritional utilization and commercial applications.
This innovative technology ensures optimal enzymatic activation within the body, leading to an unprecedented conversion efficiency to bioactive sulforaphane. By resolving the fundamental bioavailability issue, the company aims to revolutionize functional food applications. Driven by the compound’s diverse applications, particularly its potential in anti-tumor therapies, mental health support, and digestive health management, ongoing technological advancements focused on enhancing efficiency, usability, and user compliance are expected to unlock a multi-billion-dollar market for sulforaphane across emerging sectors.
Yongwei Hu, CEO & Chairman of Bon, stated that with a scheduled market entry in Q2 2025, this advancement is expected to transform and significantly expand the broccoli-derived wellness market, especially in functional foods and beverages, holding immense market potential and poised to fuel considerable industry growth due to its unique value proposition.
About Bon Natural Life Limited (“BON”)
BON, incorporated in the Cayman Islands, operates in the natural, health, and personal care industries. Additional details are available on the company website at .
For further details, please contact:
Cindy Liu | IR
Email:
Safe Harbor Statement
This press release contains statements that may be considered “forward-looking statements.” These include all statements that are not historical facts and are often identified by terms like “believes” or “expects.” These statements involve known and unknown risks and uncertainties. While the Company believes these forward-looking statements are reasonable, they are based on assumptions, risks, and uncertainties, and actual results may differ materially. Readers are cautioned not to place undue reliance on these statements, which are relevant only as of the release date. Factors that could cause actual results to differ include those discussed in the Company’s filings with the Securities and Exchange Commission, available on its website (http://www.sec.gov). All forward-looking statements made by the Company or its representatives are qualified by these factors. The Company undertakes no obligation to update these statements unless required by securities laws.
